Zymeworks Inc.
ZYME
$12.27
-$0.28-2.23%
| Weiss Ratings | ZYME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | ZYME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ZYME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.43 | |||
| Price History | ZYME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.90% | |||
| 30-Day Total Return | -16.76% | |||
| 60-Day Total Return | -2.46% | |||
| 90-Day Total Return | -10.44% | |||
| Year to Date Total Return | -16.98% | |||
| 1-Year Total Return | 13.93% | |||
| 2-Year Total Return | 44.86% | |||
| 3-Year Total Return | 104.50% | |||
| 5-Year Total Return | -49.46% | |||
| 52-Week High % Change | -29.10% | |||
| 52-Week Low % Change | 57.47% | |||
| Price | ZYME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $17.70 | |||
| 52-Week Low Price | $7.97 | |||
| 52-Week Low Price (Date) | Apr 26, 2024 | |||
| 52-Week High Price (Date) | Nov 12, 2024 | |||
| Valuation | ZYME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 873.19M | |||
| Enterprise Value | 567.52M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.62 | |||
| Earnings Per Share Growth | -7.23% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 12.29 | |||
| Price/Book (Q) | 2.55 | |||
| Enterprise Value/Revenue (TTM) | 7.44 | |||
| Price | $12.27 | |||
| Enterprise Value/EBITDA (TTM) | -5.07 | |||
| Enterprise Value/EBIT | -4.71 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | ZYME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 74.72M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ZYME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 302 274 8744 | |||
| Address | 108 Patriot Drive Middletown, DE 19709 | |||
| Website | www.zymeworks.com | |||
| Country | United States | |||
| Year Founded | 2003 | |||
| Profitability | ZYME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -157.95% | |||
| Profit Margin | -160.79% | |||
| Management Effectiveness | ZYME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -14.43% | |||
| Return on Equity | -- | |||
| Income Statement | ZYME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 76.30M | |||
| Total Revenue (TTM) | 76.30M | |||
| Revenue Per Share | $1.02 | |||
| Gross Profit (TTM) | -59.02M | |||
| EBITDA (TTM) | -111.84M | |||
| EBIT (TTM) | -120.52M | |||
| Net Income (TTM) | -122.70M | |||
| Net Income Avl. to Common (TTM) | -122.70M | |||
| Total Revenue Growth (Q YOY) | 83.33% | |||
| Earnings Growth (Q YOY) | -62.31% | |||
| EPS Diluted (TTM) | -1.62 | |||
| EPS Diluted Growth (Q YOY) | -53.94% | |||
| Balance Sheet | ZYME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 225.78M | |||
| Cash Per Share (Q) | $3.02 | |||
| Total Current Assets (Q) | 300.45M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 338.77M | |||
| Current Ratio (Q) | 3.403 | |||
| Book Value Per Share (Q) | $4.91 | |||
| Total Assets (Q) | 463.09M | |||
| Total Current Liabilities (Q) | 88.29M | |||
| Total Debt (Q) | 18.53M | |||
| Total Liabilities (Q) | 124.32M | |||
| Total Common Equity (Q) | 338.77M | |||
| Cash Flow | ZYME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 38.76M | |||
| Cash from Financing (TTM) | -20.45M | |||
| Net Change in Cash (TTM) | -91.45M | |||
| Levered Free Cash Flow (TTM) | -51.60M | |||
| Cash from Operations (TTM) | -110.04M | |||
